We invest between £0.25 – 10 million
in fast growing businesses
The Bloomsbury AI team joined the London Team of Facebook.
Freeline Therapeutics is a biopharmaceutical company focused on the development of liver-directed gene therapies. The Company will develop and commercialise gene therapies for bleeding and other debilitating disorders.
Hazy AI automates the process of anonymizing data for companies that hold vast swathes of customer information.
Matr provides one-to-one tutoring services via a proprietary online platform and aims to connect lower cost, higher quality tutoring supply from developing countries to developed economies.
MediaGamma is developing an enterprise grade reinforcement machine learning platform, delivering machine decisions in under 5 milliseconds for a new class of business problems.
MeiraGTx is a vertically integrated, clinical stage gene therapy company. It has core capabilities in viral vector design and optimization and gene therapy manufacturing, as well as a potentially transformative gene regulation technology.
Orchard Therapeutics is a biotechnology company dedicated to bringing transformative gene therapies to patients with serious and life-threatening orphan diseases. It is a spin-out from the Institute of Child Health (ICH) at UCL.
We back risk-takers and change-makers. Founders with a vision of the future and the determination to make it happen.
Albion Capital Group LLP is authorised and regulated by the Financial Conduct Authority.
Registered in England No. OC341254 Registered Office: 1 King's Arms Yard, London, EC2R 7AF. Member of the British Venture Capital Association